News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Boehringer Ingelheim Corporation Gets EU Nod For AIDS Drug
October 26, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FRANKFURT, Oct 26 (Reuters) - Boehringer Ingelheim, Germany's top drugmaker by sales, has won European approval for its Aptivus anti-AIDS drug, the unlisted firm said on Wednesday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Boehringer Ingelheim
MORE ON THIS TOPIC
Government
CDER Employees Leave FDA in Droves Amid HHS Overhaul
July 17, 2025
·
2 min read
·
Tristan Manalac
Neuropsychiatric disorders
Otsuka, Lundbeck’s PTSD Bid for Rexulti Hits Speedbump as FDA Questions Efficacy
July 17, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Sarepta Tags DMD Gene Therapy Elevidys With Black Box Warning, Axes 500 Staff
July 16, 2025
·
2 min read
·
Heather McKenzie
Antibody-drug conjugate
GSK’s Blenrep DREAMMs Turn Fitful as FDA Questions Comeback in Multiple Myeloma
July 16, 2025
·
2 min read
·
Tristan Manalac
